Summary & Overview
HCPCS V5171: Hearing Aid, Contralateral Routing Device, Monaural ITE
HCPCS Level II code V5171 denotes a monaural in-the-ear (ITE) contralateral routing hearing aid used to route sound from one ear to the opposite ear for patients with unilateral hearing impairment. Nationally, this code matters because it identifies a specific durable medical device category that affects coverage determinations, claims processing, and benefit design for hearing services. Payers commonly apply distinct coverage criteria and prior authorization rules for hearing aids and assistive devices.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for contralateral routing devices, typical sites of service where the device is provided, and the types of benchmarks and policy elements usually examined for such codes, including coverage policies, prior authorization patterns, and reimbursement considerations. The publication also outlines where data was available and where input was not provided.
This summary equips billing staff, audiology providers, and policy analysts with a clear description of the code and what to expect in payer policy review. Data not available in the input is noted where applicable; the content focuses on national implications rather than state-specific rules.
Billing Code Overview
HCPCS Level II code V5171 represents a hearing aid, contralateral routing device, monaural, in the ear (ITE). This device is designed to route sound from one ear to the opposite ear for patients with unilateral hearing loss or single-sided deafness.
Service type: Hearing aid device fitting/provision
Typical site of service: Audiology clinic or hearing aid dispensing center; may also be provided in outpatient ENT or audiology departments.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with single-sided severe-to-profound sensorineural hearing loss is evaluated in the audiology clinic. The patient reports poor sound awareness on the affected side and difficulty understanding speech in noisy environments. After diagnostic pure-tone audiometry, speech discrimination testing, and a review of medical history, the audiologist and otolaryngologist determine that a contralateral routing of signal (CROS) hearing solution is appropriate. The device is fitted as an in-the-ear (ITE) contralateral routing device billed with V5171.
The clinical workflow includes: baseline audiometric assessment, candidacy counseling, ear impression for custom ITE shell fabrication, trial fitting of the monaural contralateral routing device, real-ear or coupler verification of gain and output as applicable, patient orientation and device programming, and scheduled follow-up for fine-tuning and verification. Documentation includes diagnostic test results, medical necessity rationale referencing unilateral severe hearing loss, device description as Hearing aid, contralateral routing device, monaural, in the ear (ITE) and itemized device charges for billing under V5171.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |